Earnings Feed
Start Free
Home/Filings/4/0001855763-22-000002
4//SEC Filing

McKechnie William Edward 4

Accession 0001855763-22-000002

CIK 0001348362other
View on SEC.govCompany Profile

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 5:27 PM ET

Size

9.3 KB

Accession

0001855763-22-000002

Insider Transaction Report

Form 4
Period: 2022-03-08
Lexaria Bioscience Corp.LEXX
McKechnie William Edward
Director
Transactions
  • Award

    Stock Options

    2022-03-08+3,400→ 11,800 total
    Exercise: $3.39From: 2022-03-08Exp: 2027-03-08→ Common Shares (3,400 underlying)
Holdings

  • common shares

    13,191

  • Stock Options

    Exercise: $5.31From: 2021-04-26Exp: 2026-04-26→ Common Shares (1,500 underlying)
    1,500

  • Stock Options

    Exercise: $6.23From: 2021-09-01Exp: 2026-09-01→ Common Shares (1,900 underlying)
    8,400

  • Stock Options

    Exercise: $7.08From: 2021-06-08Exp: 2026-06-08→ Common Shares (5,000 underlying)
    6,500

Documents

1 file

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

→
Entity typeother

Related Parties

1
  • filerCIK 0001658613

Filing Metadata

Form type
4
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 5:27 PM ET
Size
9.3 KB
View on SEC.gov